97 related articles for article (PubMed ID: 263355)
1. L-dopa absorption and the pituitary-hypothalamic axis.
Boyd AE; Angoff G; Long A; Mager M
J Clin Endocrinol Metab; 1978 Dec; 47(6):1341-7. PubMed ID: 263355
[TBL] [Abstract][Full Text] [Related]
2. Pooled prolactin measurements in the evaluation of short children.
Shulman DI; Hu CS; Root AW; Bercu BB
J Clin Endocrinol Metab; 1989 Dec; 69(6):1261-7. PubMed ID: 2511222
[TBL] [Abstract][Full Text] [Related]
3. Abnormal growth hormone responsiveness to stimuli in women with active celiac sprue.
Peracchi M; Molteni N; Cantalamessa L; Bardella MT; Peracchi G; Orsatti A; Faggioli P; Bianchi PA
Am J Gastroenterol; 1992 May; 87(5):580-3. PubMed ID: 1595643
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
[TBL] [Abstract][Full Text] [Related]
5. [The effects of l-dopa administration on the prolactin levels in short-stature subjects].
Saggese G; Cesaretti G; Carlotti C; Cioni C; Bracaloni C
Minerva Pediatr; 1992 Mar; 44(3):73-8. PubMed ID: 1518496
[TBL] [Abstract][Full Text] [Related]
6. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
Fine SA; Frohman LA
J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
[TBL] [Abstract][Full Text] [Related]
7. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
Camanni F; Picotti GB; Massara F; Molinatti GM; Mantegazza P; Müller EE
J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic-pituitary control of perinatal prolactin secretion in Macaca mulatta.
Epstein MF; Chez RA; Oakes GK; Vaitukaitis JL
Endocrinology; 1976 Sep; 99(3):743-51. PubMed ID: 821744
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of cimetidine on L-dopa-stimulated growth hormone release in normal man.
Zanoboni A; Galmozzi G; Marinoni S; Zanoboni-Muciaccia W
Clin Endocrinol (Oxf); 1984 Nov; 21(5):535-40. PubMed ID: 6499233
[TBL] [Abstract][Full Text] [Related]
10. Calcium and calcium-antagonistic effects on prolactin and growth hormone responses to thyrotropin-releasing hormone and L-dopa in man.
Röjdmark S; Andersson DE; Sundblad L
J Clin Endocrinol Metab; 1981 Sep; 53(3):594-8. PubMed ID: 6790560
[TBL] [Abstract][Full Text] [Related]
11. [The correlationship between basal prolactin levels and the suppressive effect of CB-154 or L-DOPA on GH release in acromegalic patients (author's transl)].
Hara I; Kataoka K; Tomita A; Takanohashi M; Nakane T; Kuwayama A; Kageyama N
Nihon Naibunpi Gakkai Zasshi; 1979 Jan; 55(1):16-24. PubMed ID: 581754
[TBL] [Abstract][Full Text] [Related]
12. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
[TBL] [Abstract][Full Text] [Related]
13. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
De Marinis L; Mancini A; Zuppi P; Fiumara C; Iacona T; Conte G; Fabrizi ML; Valle D; Anile C; Maira G
Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567
[TBL] [Abstract][Full Text] [Related]
14. Hypothalamo-pituitary dopaminergic system in patients with myotonic dystrophy.
Sakuma H; Takase S; Mizuno Y; Teramura K; Hanew K
Tohoku J Exp Med; 1988 Nov; 156(3):291-8. PubMed ID: 3252557
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamic and pituitary sites of action of oxytocin to alter prolactin secretion in the rat.
Lumpkin MD; Samson WK; McCann SM
Endocrinology; 1983 May; 112(5):1711-7. PubMed ID: 6403333
[TBL] [Abstract][Full Text] [Related]
16. Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients.
Lissoni P; Malugani F; Casu M; Bukovec R; Egardi R; Bordin V; Fumagalli E; Mengo S; Gardani G
Neuro Endocrinol Lett; 2002 Feb; 23(1):61-3. PubMed ID: 11880864
[TBL] [Abstract][Full Text] [Related]
17. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.
Tapanainen P; Knip M; Lautala P; Leppäluoto J
J Clin Endocrinol Metab; 1988 Oct; 67(4):845-9. PubMed ID: 3138280
[TBL] [Abstract][Full Text] [Related]
18. [Behavior of growth hormone after stimulation with growth hormone releasing hormone (GHRH) in children with disorders of the hypothalamo-hypophyseal axis and girls with Turner syndrome].
Schmitt K; Schober E; Birnbacher R; Frisch H
Klin Padiatr; 1996; 208(1):29-34. PubMed ID: 8851324
[TBL] [Abstract][Full Text] [Related]
19. [Responses of growth hormone and prolactin to L-Dopa in women with polycystic ovarian syndrome].
Wu X; Gu Q; Su Y
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):489-91. PubMed ID: 9639745
[TBL] [Abstract][Full Text] [Related]
20. Effect of experimentally induced hyperprolactinemia on growth hormone secretion.
Esquifino AI; Fernández-Ruiz JJ; Cebeira M; Agrasal C; Tresguerres JA; Ramos JA
Rev Esp Fisiol; 1987 Dec; 43(4):463-8. PubMed ID: 3448711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
